Raphael Pharmaceutical Inc RAPH
$1.40
Last Updated: Jul 28, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
Raphael Pharmaceutical Inc. Stock Analysis RAPH
United States N/A Nano Cap Raphael Pharmaceutical, Inc. is a clinical-stage biotechnology company. The firm is focused on the discovery and clinical development of life-improving drug therapies based on cannabinoids, including cannabidiol (CBD) oil. The firm has completed the study for its lead product candidate for the treatment of rheumatoid arthritis (RA), and is developing asthma product candidates, which are in the pre-clinical-stage. The firm is also continuing to investigate its product for the treatment of autoimmune diseases. The Company’s discovery platform focuses on the use of CBD oil, one of the cannabinoids in cannabis plants, as the active pharmaceutical ingredient (API), for its RA product candidate and COVID-19 product candidate.
Raphael Pharmaceutical Inc (RAPH) Chart
Financial Metrics & Statements of Raphael Pharmaceutical Inc (RAPH)
FAQ's for Raphael Pharmaceutical Inc (RAPH)
- As of August 2026, Raphael Pharmaceutical Inc RAPH is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Raphael Pharmaceutical Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Raphael Pharmaceutical Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Raphael Pharmaceutical Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Raphael Pharmaceutical Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Raphael Pharmaceutical Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Raphael Pharmaceutical Inc (RAPH)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
